Charcot neuroarthropathy after Simultaneous Pancreas Kidney transplantation: risk factors and evolution of prevalence over 20 years. Prof. Dr. GA Matricali.

Slides:

Advertisements

Similar presentations

Everolimus plus Reduced-Exposure CsA is as Effi cacious as Mycophenolic Acid plus Standard-Exposure CsA Reference: Silva Jr HT, Cibrik D, Johnston T, et.

Advertisements

Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.

What makes a pancreas allograft marginal? Peter J Friend University of Oxford.

CHAPTER 3 HEART AND LUNG TRANSPLANTATION Editors: Mr Mohamed Ezani Md. Taib Dato’ Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani.

Effect of Obesity on Kidney Transplantation Reference: Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56:143–156.

Impact of expanded criteria donors on patient survival after heart, lung, liver and combined organ transplantation Quebec experience from 2003 to 2009.

Recent management of Renal Transplantation in a Developing Country like Bangladesh, R Alam, Islam M S, R Alam, H Rahman, HU Rashid Department of Nephrology,

Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.

Kidney Transplantation An Overview

The Role of Pancreas Transplantation in the Long Term Management of Diabetes Christopher Johnson MD Professor of Surgery Division of Transplant Surgery.

SSA Hearing on Compassionate Allowances Janet N Scheel MD November 9,2010.

CM-1 Clinical Transplantation Lung Howard University Hospital Department of Transplantation Clive O. Callender, MD. Arturo Hernandez, MD.

Pancreatic and Islet Cell Transplantation. GENERAL PRINCIPLES Pancreas graft survival rates have significantly improved over the past decade, and now.

UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.

Dr. Charu Kartik Senior Clinical Dietitian KFSH&RC,Riyadh Dr. Charu Kartik Senior Clinical Dietitian KFSH&RC,Riyadh NUTRITIONAL CO-MORBITIES POST RENAL.

PREDICTING AKI IS MORE CHALLENGING AS AGE PROGRESSES Sandra Kane-Gill, PharmD, MSc Associate Professor, School of Pharmacy.

Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients

Tolerance Induction after Kidney Transplantation Stephan Busque MD M Sc FRCSC Director, Adult Kidney and Pancreas Transplantation Program Stanford University.

Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes The TODAY clinical trial Featured Article: TODAY Study Group* Diabetes Care Volume.

Management of diabetes mellitus and its complications – comparative study - between a Romanian and a German Diabetes Care Center Author: Feier Ingrid Coordinator:

PREVALENCE OF RISK FACTORS FOR DIABETIC FOOT ULCER AND RISK STRATIFICATION IN TYPE 2 DIABETES DR. NEETA DESHPANDE ASSOCIATE PROF.,JN MEDICAL COLLEGE AND.

Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.

HEART TRANSPLANTATION Pediatric Recipients JHLT Oct; 32(10):

Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients

實習生 : 中山醫李佳靜指導老師 : 陳燕慈營養師 The Relationship of BMI and Lung Transplant Recipients 1.

Section 5: Configuration of healthcare to manage CKD.

Experience with Calcineurin Inhibitor-Free Immunosuppression in Kidney Transplantation with Marginal Donors Oppenheimer F, Saval N, Gutierrez A, Cam pistol.

Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.

TRANSPLANTATION CHAPTER 8 ANZDATA Registry Annual Report 2013.

CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

3 Patrick T Anderson, 2,3 Vivian McAlister, 1,3 Alp Sener, 1,3 Patrick P Luke Divisions of 1 Urology and 2 Surgery, Department of Surgery, 3 Schulich School.

Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients

Journal Club : Relationship between Intraoperative Mean Arterial Pressure and Clinical Outcomes after Noncardiac Surgery Toward an Empirical Definition.

CR-1 Everolimus Benefit/Risk Assessment Howard J. Eisen, MD Thomas J. Vischer Professor of Medicine Chief, Division of Cardiology Drexel University College.

CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.

Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.

HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):

© 2014 Direct One Communications, Inc. All rights reserved. 1 How to Maximize Outcomes and Minimize Graft Failure Thin Thin Maw, MBBS Washington University.

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.

Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial Featured Article: TODAY Study Group* Diabetes Care Volume 36:

Mechanical Circulatory Support in Special Populations Renzo Y. Loyaga-Rendon MD.,PhD.. Assistant Professor Advanced Heart Failure Section University of.

Hexabrix Key Clinical Review Liss, 2006 Mid-Year Sales Meeting Bloomington, IN July 13 th – 17 th.

CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:

Implementation of RRT improved the survival rate significantly, when blood urea nitrogen or serum creatinine was still low level. However, most of those.

Results Methods Abstract Number 69 Objectives 1.Nephrol Dial Transplant (2011) 26: 537–543 2.J Support Oncol 2011;9:149–155 3.N Engl J Med. 2009; 361:1627–1638.

TM RAPAMUNE ® O-1 RAPAMUNE ® Overview John F. Neylan, MD Vice President, Transplantation Immunology Clinical Research and Development Wyeth-Ayerst Research.

Is BMI a Justified Contraindication for Kidney Transplantation? Introduction OHSU’s Kidney Transplant Program has set a BMI >35 kg/m 2 as a relative contraindication.

What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.

Thymoglobulin: An Overview of Its Performance in Clinical Trials as an Agent for the Induction Therapy Reference: Osama Gaber A, Knight RJ, Patel S, et.

Retrospective Monocentric 10-Year Analysis Of Sepsis-Associated Acute Kidney Injury: Impact On Outcome, Dialysis Dose And Residual Renal Function 1 Vincenzo.

Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.

Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.

R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.

Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.

Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.

Heart transplantation (HTx) provides satisfactory long-term survival for patients with severe cardiomyopathy due to a variety of causes. Despite considerable.

Evaluation of morbidity and mortality outcomes in heart transplant patients with and without diabetes after implementation of a tacrolimus monotherapy.

CM-1 Current Status of Lung Transplantation Jeff Golden, MD Professor of Clinical Medicine and Surgery Medical Director, Lung Transplantation University.

Epstein-Barr virus re-activation in post-kidney transplant period: risk factors and specific immune- responses Erica Franceschini.

Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation J Am Soc Nephrol 27: 1793–1800, 2016 순천향 대학병원 신장내과 강혜란.

Outcomes of bariatric surgery after renal transplant: single center experience in Kuwait Authors Gheith O, Al-Otaibi T, Nampoory MRN, Halim M, Saied T,

Table 3.1.1a: Stock and Flow of Heart Transplantation,

Number of Grafts Performed by Country

Volume 57, Issue 5, Pages (May 2000)

Volume 54, Issue 4, Pages (October 1998)

T. Rana, L. Szabo, A. Asderakis, E. Ablorsu

Section 5: Configuration of healthcare to manage CKD

Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center Jan Groetzner, MD, Bruno Reichart, MD, Ulrich Roemer, MD, Stefanie.

Current induction and maintenance treatment choices for proliferative lupus nephritis. Current induction and maintenance treatment choices for proliferative.

Presentation transcript:

Charcot neuroarthropathy after Simultaneous Pancreas Kidney transplantation: risk factors and evolution of prevalence over 20 years. Prof. Dr. GA Matricali Fernando García Barrado Prof. Dr. D Kuypers

Objective Evaluate risk factors for developing Charcot foot (CF) in a SPK-population Evolution in prevalence of CF Comparison of 2 cohorts (1992 – 1999; 1999 – 2012)

Introduction CF is present in 0.1 to 0.4% 1 of the general diabetes population Etiology of CF o French theory (Charcot) o Neurovascular theory o Neurotraumatic theory SPK: golden standard therapy for diabetes mellitus 1 (DM1) and end stage kidney failure (ESKF). 1 Coughlin M.J., Mann R.A., Saltzman C. Charcot neuroarthropathy of the foot in the diabetic patient: Do not delay the diagnosis and management. Surgery of the Foot and Ankle. 2007;2: 101 Jean-Martin Charcot

Materials and methods (1) Retrospective study Diabetes Mellitus type 1 and ESKF SPK in UZ Leuven Transplanted between 1992 en 2012 (n = 100) Medical files: electronic and paper Clinical and radiographic diagnosis

Materials and methods (2) Sex BMI Age at transplantation Retinopathy Duration and type of RRT Duration of DM Number of acute rejections Transplant outcome Drainagesite Donorkidney and implantation site Serum value: o Hba1c o Creatinine o Calcium o Phosphate Maintenance therapy: o CS o CsA o Tac o MMF o Aza

Results 9/100 (9%) developed CF, of which 4 in the first year post-transplant Higher mortality in CF patients (56 vs. 18% [p= 0.019]) Higher HbA1c serum values pre-transplant (p= 0.021) More acute rejections in CF group (78 vs 41% [p= 0.041]) Worse graft survival in CF group (33 vs 78% [p= 0.009]) Higher serum phosphate 1 year post-transplant in CF group (p= 0.04) 7/39 (18%) patients in the first cohort developed CF, only 2/61 (3%) in the second cohort (p= 0.026) Bladder drainage in cohort 1 (95%), in cohort 2 (10%) [p< ]

Immuunsuppressiva CF vs Non CF CF Non CF P = P = P = P = P = Azathioprine Cyclosporine A Mycophenolaat mofetil Tacrolimus P = P = P = P = P = Methylprednisolone (g)

Immuunsuppressiva cohorts <1999 ≥1999 P< Azathioprine Cyclosporine A Mycophenolaat mofetil Tacrolimus P< Methylprednisolone (g)

Discussion Diabetes and CF: o Etiology o HbA1c Corticosteroids o Suppression of bone formation o Less formation of type 1 collagen o Excessive bone resorption Maintenance immunosuppressive therapy

Conclusion Further research is necessary Importance of good glycemic control Avoidence of CS in maintenance therapy Importance of early detection The author declares that the research for and communication of this independent body of work does not constitute any financial or other conflict of interest.

Thank you for your attention